Subscribe

CSPC Innovation Pharmaceutical Co., Ltd. (300765.SZ)

CNY42.00 +4.61 (+12.33%)
CN SHZ Consumer Defensive Packaged Foods
Address No. 36, Fuqiang Western Road 51430
Shijiazhuang, CN
CEO Bing Yao
IPO 2019-03-22
ISIN CNE100003K04

Explore sections of this company profile

Description

Operating from its base in Shijiazhuang, China, CSPC Innovation Pharmaceutical Co., Ltd. specializes in the manufacturing and commercialization of caffeine, vitamin C, health supplements, and various beverage offerings. The company functions as a subsidiary of the larger entity, CSPC Pharmaceutical Group Limited.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
CNY42.00 +4.61 (+12.33%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
13M
Beta
0.10
Float Shares
323.18M
Free Float %
23.0%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+2.76% -9.32% -11.89% -18.98% -17.59% -25.81% -48.45% +141.52% +287.83% +347.49% +347.49%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
42.00
Ratings Trend (MoM) 100% Bullish
Rating 2026-05 Change
Strong Buy 1 0
Buy 3 0
Hold 0 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
6.81
Safe zone
Piotroski F-Score
3 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
4 / 5
High
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
  • Revenue growth Packaged Foods: +4.4%
    +8.4% Q1'26: +40.8% (vs Q1'25)
  • EPS growth Packaged Foods: +14.6%
    -542.7% Q1'26: -251.0% (vs Q1'25)
  • FCF margin FCF growth · Packaged Foods: +15.9%
    -25.1% Q1'26: -42.9% (vs Q1'25)
  • EBIT margin Packaged Foods: +7.9%
    -29.1% Q1'26: -15.9% (vs Q1'25)
  • ROIC Packaged Foods: +7.0%
    -38.1% Q1'26: -23.7% (vs Q1'25)
  • Share dilution Packaged Foods: +0.0%
    -0.5% Q1'26: -0.6% (vs Q1'25)
  • Debt / EBITDA Net debt/EBITDA · Packaged Foods: 0.19×
    -0.01× Q1'26: -0.22× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.20) × ERP
WACC = 100% × Ke + 0% × Kd (462.1%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Current price: 42.00
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2023
actual
Dec 2023
actual
Dec 2024
actual
Dec 2025
actual
Dec 2026
3 Rev. Ana.
2 EPS Ana.
Dec 2027
3 Rev. Ana.
2 EPS Ana.
Dec 2028
2 Rev. Ana.
2 EPS Ana.
Revenue
2.63B
est: 2.13B (+23.4%)
2.54B
est: 2.13B (+19.2%)
1.98B
est: 2.01B (-1.2%)
2.15B
est: 2.24B (-4.3%)
3.52B
3.16B – 4.15B
+57.0% YoY
3.93B
2.95B – 5.21B
+11.7% YoY
4.82B
3.94B – 6.07B
+22.6% YoY
EBITDA
924.67M
est: 267.23M (+246.0%)
417.53M
est: 267.23M (+56.2%)
1.76M
est: 251.71M (-99.3%)
-402.58M
est: 281.50M (-243.0%)
441.82M
397.07M – 520.30M
+57.0% YoY
493.53M
370.61M – 654.29M
+11.7% YoY
604.97M
494.83M – 761.39M
+22.6% YoY
EBIT
852.55M
est: 122.88M (+593.8%)
262.78M
est: 122.88M (+113.8%)
-214.52M
est: 115.75M (-285.3%)
-625.82M
est: 129.45M (-583.4%)
203.17M
182.59M – 239.26M
+57.0% YoY
226.95M
170.43M – 300.88M
+11.7% YoY
278.20M
227.55M – 350.13M
+22.6% YoY
Net Income
726.28M
est: 627.69M (+15.7%)
434.44M
est: 627.69M (-30.8%)
53.73M
est: 121.04M (-55.6%)
-241.13M
est: 58.47M (-512.4%)
555.64M
278.02M – 833.27M
+850.2% YoY
730.18M
326.62M – 1.13B
+31.4% YoY
1.03B
848.09M – 1.20B
+40.9% YoY
SGA
312.29M
est: 269.02M (+16.1%)
302.21M
est: 269.02M (+12.3%)
233.37M
est: 253.40M (-7.9%)
216.55M
est: 283.39M (-23.6%)
444.79M
399.73M – 523.79M
+57.0% YoY
496.84M
373.09M – 658.68M
+11.7% YoY
609.02M
498.14M – 766.50M
+22.6% YoY
EPS
0.54
est: 0.46 (+18.4%)
0.31
est: 0.46 (-32.0%)
0.04
est: 0.08 (-53.6%)
-0.17
est: 0.04 (-525.0%)
0.40
0.20 – 0.60
+897.5% YoY
0.52
0.23 – 0.81
+31.4% YoY
0.73
0.61 – 0.86
+40.1% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-29 C- 1/5 1/5 1/5 1/5 4/5 1/5 1/5
2026-05-28 C- 1/5 1/5 1/5 1/5 4/5 1/5 1/5
2026-05-27 C- 1/5 1/5 1/5 1/5 4/5 1/5 1/5
2026-05-26 C- 1/5 1/5 1/5 1/5 4/5 1/5 1/5
2026-05-25 C- 1/5 1/5 1/5 1/5 4/5 1/5 1/5
2026-05-22 C- 1/5 1/5 1/5 1/5 4/5 1/5 1/5
2026-05-21 C- 1/5 1/5 1/5 1/5 3/5 1/5 1/5
2026-05-20 C- 1/5 1/5 1/5 1/5 3/5 1/5 1/5
2026-05-19 C- 1/5 1/5 1/5 1/5 3/5 1/5 1/5
2026-05-18 C- 1/5 1/5 1/5 1/5 3/5 1/5 1/5
2026-05-15 C- 1/5 1/5 1/5 1/5 3/5 1/5 1/5
2026-05-14 C- 1/5 1/5 1/5 1/5 3/5 1/5 1/5
2026-05-13 C- 1/5 1/5 1/5 1/5 3/5 1/5 1/5
2026-05-12 C- 1/5 1/5 1/5 1/5 3/5 1/5 1/5
2026-05-11 C- 1/5 1/5 1/5 1/5 3/5 1/5 1/5
2026-05-08 C- 1/5 1/5 1/5 1/5 3/5 1/5 1/5
2026-05-07 C- 1/5 1/5 1/5 1/5 3/5 1/5 1/5
2026-05-06 C- 1/5 1/5 1/5 1/5 3/5 1/5 1/5
2026-04-30 C- 1/5 1/5 1/5 1/5 3/5 1/5 1/5
2026-04-29 C- 1/5 1/5 1/5 1/5 3/5 1/5 1/5
2026-04-28 C- 1/5 1/5 1/5 1/5 3/5 1/5 1/5
2026-04-27 C- 1/5 1/5 1/5 1/5 3/5 1/5 1/5
2026-04-24 C- 1/5 1/5 1/5 1/5 3/5 1/5 1/5
2026-04-23 C- 1/5 1/5 1/5 1/5 3/5 1/5 1/5
2026-04-22 C- 1/5 1/5 1/5 1/5 3/5 1/5 1/5
2026-04-21 C- 1/5 1/5 1/5 1/5 3/5 1/5 1/5
2026-04-20 C- 1/5 1/5 1/5 1/5 3/5 1/5 1/5
2026-04-17 C- 1/5 1/5 1/5 1/5 3/5 1/5 1/5
2026-04-16 C- 1/5 1/5 1/5 1/5 3/5 1/5 1/5
2026-04-15 C- 1/5 1/5 1/5 1/5 3/5 1/5 1/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
-655.39M
OE per share TTM
-0.47
Owner's Yield
-1.76%
Maintenance CapEx ratio
Maint CapEx / Avg PPE
81.4%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
Total invested
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock Held by 114 ETFs in our universe
# ETF Weight Est. AUM exposure TER
1 KraneShares MSCI All China Health Care Index ETF KURE 0.97% 775.0K 0.79%
2 VanEck ChiNext ETF CNXT 0.21% 258.4K 0.65%
3 HSBC MSCI China A UCITS ETF HMCT.L 0.19% 254.7K 0.30%
4 iShares MSCI China A ETF CNYA 0.09% 216.9K 0.60%
5 iShares MSCI China A UCITS ETF CNYA.L 0.09% 2.82M 0.40%
6 iShares MSCI China A UCITS ETF CNYE.MI 0.09% 93.1K 0.45%
7 Amundi MSCI China A UCITS ETF Acc CNAA.L 0.07% 104.1K 0.35%
8 Xtrackers MSCI China A UCITS ETF 1C XX2D.L 0.06% 85.5K 0.35%
9 HSBC MSCI AC Asia Pacific ex Japan Climate Paris Aligned UCITS ETF USD HPAJ.L 0.06% 10.5K 0.25%
10 Invesco MSCI China All Shares Stock Connect UCITS ETF MCHN.L 0.04% 45.5K 0.35%

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
-251.6K
Shares Outstanding
1.40B

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Bing Yao Executive Chairman
Hong Chao Li Head of Accounting
Long Dai GM, CFO & Director male
Wen Xu Secretary & Director female
Xiwu Hui Deputy General Manager
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits